— Know what they know.
Not Investment Advice
Also trades as: 0IDA.L (LSE) · $vol 0M

DVAX NASDAQ

Dynavax Technologies Corporation
1W: +38.2% 1M: +43.6% 3M: +49.6% 1Y: +18.3% 3Y: +42.5% 5Y: +174.6%
$15.50
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $1.8B mcap · 100M float · 3.15% daily turnover · Short 43% of daily vol

Cash Flow Trends

Operating Cash Flow
$67M -33.9% ▼
Capital Expenditures
$6M -54.8% ▼
5Y CAGR: -26.4%
Free Cash Flow
$60M -37.6% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$100M +0.0% ▲
Net Change in Cash
-$54M -5.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$75M$77M$293M-$6M$27M
Depreciation & Amort.$9M$7M$7M$7M$8M
Stock-Based Comp.$13M$21M$33M$43M$53M
Change in Working Capital-$33M$172M-$298M$61M-$16M
Other Non-Cash Items-$7M$58M-$33M$1M-$5M
Operating Cash Flow-$92M$336M$63M$101M$67M
— Investing Activities —
Capital Expenditures-$4M-$9M-$7M-$4M-$6M
Acquisitions (Net)$0$0$1M$1M$0
Investment Purchases-$202M-$165M-$632M-$637M-$524M
Investment Sales$179M$188M$322M$486M$512M
Other Investing-$149K$1M$0$0$0
Investing Cash Flow-$27M$14M-$316M-$154M-$18M
— Financing Activities —
Net Debt Issuance$0$30M$0$0$0
Stock Repurchased$0$0$0$0-$100M
Dividends Paid$0$0$0$0$0
Other Financing$961K-$2M$1M-$5M-$2M
Financing Cash Flow$109M$56M$20M$1M-$102M
Net Change in Cash-$8M$404M-$234M-$52M-$54M
Cash End of Period$32M$436M$202M$151M$96M
Free Cash Flow-$103M$326M$56M$96M$60M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms